Bepranemab (UCB 0107) 是一种人源化全长 IgG4 单克隆抗体，可与中央 tau 表位（氨基酸 235-250）结合。Bepranemab 可用于阿尔茨海默病 (AD) 研究。
| 生物活性 | Bepranemab (UCB 0107) is a humanized, full-lengthIgG4monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research[1]. |
| CAS 号 | |
| 中文名称 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
